Alimera Sciences Inc reports results for the quarter ended in September - Earnings Summary

Alimera Sciences

26/10/2023 14:32

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 6 cents per share.
    * Revenue rose 71.8% to $23.36 million from a year ago;
analysts
expected $22.72 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 6 cents​.
    * The mean earnings estimate of analysts had fallen by
about 261.2% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had risen by 1.0% this
quarter and
gained 15.5% so far this year.
    * The company reported a quarterly loss of $1.93 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.06          -0.06          Met
 Jun. 30 2023      0.02           -1.32          Missed
 Mar. 31 2023      -0.32          -0.71          Missed
 Dec. 31 2022      -0.33          -0.54          Missed